Combination of Isoliquiritigenin and Vancomycin Alleviates Staphylococcus aureus ‐Induced Bone Infection in Rats
APMIS · 2025
DOI: 10.1111/apm.70056 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Mingbo Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Trauma Surgery Section B, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Chalcones, Staphylococcal Infections, Vancomycin, Osteomyelitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Inner Mongolia Autonomous Region science and technology plan project, Joint project plan of Inner Mongolia Medical University.
Abstract (Originalsprache)
Staphylococcus aureus ( S. aureus )‐induced osteomyelitis presents therapeutic challenges due to antibiotic resistance. Isoliquiritigenin (ISL), a licorice‐derived chalcone, exhibits antibacterial and anti‐inflammatory properties. This study evaluated vancomycin (VAN) combined with ISL against methicillin‐resistant S. aureus (MRSA)‐induced implant‐related osteomyelitis. A rat model was established by tibial MRSA inoculation with simultaneous Kirschner wire implantation. Four weeks postinfection, rats were divided into five groups: normal, model, VAN (50 mg/kg), ISL (100 mg/kg), and VAN + ISL. After 14 days of treatment, combined therapy significantly reduced bone infection severity and histopathological scores versus monotherapies ( p < 0.001), decreased serum inflammatory markers (IL‐6, TNF‐α, IL‐1β, and CRP; p < 0.001), and reduced bacterial loads in bone/wire ( p < 0.001). In vitro, ISL (50 μM) attenuated MRSA‐induced inflammatory response in MC3T3‐E1 osteoblasts by suppressing NF‐κB and MAPK signaling, while promoting osteogenesis via increased Runx2/BMP2/ALP expression, activated BMP/Smad signaling, and enhanced mineralization. Overall, VAN + ISL combination therapy outperforms monotherapy by concurrently eradicating MRSA, suppressing inflammation, and promoting bone repair, representing a promising synergistic strategy for recalcitrant osteomyelitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Trauma Surgery Section B, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
- Graduate School of Inner Mongolia Medical University, Hohhot, China.
- Trauma Surgery Section A, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
- Department B of Joint Surgery, the Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
- Joint Surgery Section C, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
ORCID-Profile: Huicheng Lv
Förderung
- Inner Mongolia Autonomous Region science and technology plan project
- Joint project plan of Inner Mongolia Medical University
Zitieren
APA
Wang, M., Lv, H., Han, L., Jia, H., Zhang, L., Wang, L., He, A., & Du, Y. (2025). Combination of Isoliquiritigenin and Vancomycin Alleviates Staphylococcus aureus ‐Induced Bone Infection in Rats. APMIS. https://doi.org/10.1111/apm.70056
Vancouver
Wang M, Lv H, Han L, Jia H, Zhang L, Wang L, et al. Combination of Isoliquiritigenin and Vancomycin Alleviates Staphylococcus aureus ‐Induced Bone Infection in Rats. APMIS. 2025. doi:10.1111/apm.70056
BibTeX
@article{Wang2025,
author = {Wang, Mingbo and Lv, Huicheng and Han, Long and Jia, Haisheng and Zhang, Lifeng and Wang, Lei and He, Aimin and Du, Yu},
title = {Combination of Isoliquiritigenin and Vancomycin Alleviates Staphylococcus aureus ‐Induced Bone Infection in Rats},
journal = {APMIS},
year = {2025},
doi = {10.1111/apm.70056}
}
EUVIMED